PRIMO interdisciplinary challenges in SCLC
management presentation series
The following videos were captured during a live presentation from a group of multidisciplinary experts in the management of small cell lung cancer (SCLC). These experts reviewed real world cases of ES- SCLC and discussed optimal treatment of patients. The faculty include: Jason Porter, MD; Martin Dietrich, MD; Chaely Medley,AGNP-C; and Kirollos Hanna, Pharm D, BCPS, BCOP
- The learning objectives of the presentations are to:
- Review and understand appropriate, evidence based, data to support clinical decision making in SCLC
- Better understand the standard of care for SCLC, including patient assessment, treatment, and outcomes
- Integration of supportive care treatments, with a focus on optimizing treatment success
Presentation 1: Overview of SCLC Advancements & Management
Presented by: Jason Porter, MD
Presentation 2: Administration and Cost Saving Benefits of Trilaciclib.
Presented by Kirollos Hanna, PharmD, BCPS, BCOP.
Presentation 3: Impact of Chemotherapy Induced Myelosuppression and Treatment Challenges
Presented by: Chaely Medley, AGNP-C.
Presentation 4: Trilaciclib
Presented by: Martin Dietrich, MD